UNDERWRITING AGREEMENT DYNE THERAPEUTICS, INC. [●] Shares of Common Stock, par value $0.0001 per share Underwriting AgreementUnderwriting Agreement • January 19th, 2021 • Dyne Therapeutics, Inc. • Pharmaceutical preparations • New York
Contract Type FiledJanuary 19th, 2021 Company Industry JurisdictionDyne Therapeutics, Inc., a Delaware corporation (the “Company”), proposes to issue and sell to the several underwriters listed in Schedule 1 hereto (the “Underwriters”), for whom you are acting as representatives (the “Representatives”), an aggregate of [●] shares of common stock, par value $0.0001 per share (the “Common Stock”), of the Company (the “Underwritten Shares”) and, at the option of the Underwriters, up to an additional [●] shares of Common Stock of the Company (the “Option Shares”). The Underwritten Shares and the Option Shares are herein referred to as the “Shares”. The shares of Common Stock of the Company to be outstanding after giving effect to the sale of the Shares are referred to herein as the “Stock”.
SUMMARY OF BASIC LEASE INFORMATIONLease • January 19th, 2021 • Dyne Therapeutics, Inc. • Pharmaceutical preparations
Contract Type FiledJanuary 19th, 2021 Company IndustryThis Lease, which includes the preceding Summary and the exhibits attached hereto and incorporated herein by this reference (the Lease, the Summary and the exhibits to be known sometimes collectively hereafter as the “Lease”), dated as of the date set forth in Section 1 of the Summary, is made by and between BP3-BOS1 1560 TRAPELO ROAD LLC, a Delaware limited liability company (“Landlord”), and DYNE THERAPEUTICS, INC., a Delaware corporation (“Tenant”).